iRhythm

Rank#3795

Market Cap3.64B

CountryUnited States

Summary

iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. The company's Zio XT and AT monitors, a single-use, wire-free, and wearable patch-based biosensors, records patient's heartbeats and ECG data. It has a development collaboration agreement with Verily Life Sciences LLC to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.

History

iRhythm was founded in 2009 and is headquartered in San Francisco, California. The Company was founded by Dr. Ullas Naik, a veteran of the medical device industry, and his co-founder, Dr. David Rubin, Professor of Medicine at the University of California, San Francisco. In 2012, iRhythm created the Zio XT patch, an electronic monitoring patch that passively records and stores electrocardiogram (ECG) readings for 14 days.

Mission

To provide superior clinical service for patients.

Vision

Our vision is to continue to empower clinicians with actionable insights to provide better personalized arrhythmia care for patients.

References

https://in.investing.com/equities/irhythm-technologies-inc

https://finance.yahoo.com/quote/IRTC/profile?p=IRTC

https://www.comparably.com/companies/irhythm-technologies/mission

https://www.crunchbase.com/organization/irhythm

https://sec.report/CIK/0001388658

https://companiesmarketcap.com/

https://www.irhythmtech.com